Trial intelligence / Profile preview

PIOcomb: Pioglitazone vs Metformin in Insulin-Treated T2DM

NCT00770445Phase 4Completed

Sponsor
Takeda
Start
May 2008
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started May 2008; status: completed.

02

Drugs

pioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00770445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00770445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call